1
|
Yee-Lin V, Pooi-Fong W and Soo-Beng AK:
Nutlin-3, A p53-Mdm2 antagonist for nasopharyngeal carcinoma
treatment. Mini Rev Med Chem. 18:173–183. 2018. View Article : Google Scholar : PubMed/NCBI
|
2
|
Wu J and Hann SS: Functions and roles of
long-non-coding RNAs in human nasopharyngeal carcinoma. Cell
Physiol Biochem. 45:1191–1204. 2018. View Article : Google Scholar : PubMed/NCBI
|
3
|
Rupaimoole R and Slack FJ: MicroRNA
therapeutics: Towards a new era for the management of cancer and
other diseases. Nat Rev Drug Discov. 16:203–222. 2017. View Article : Google Scholar : PubMed/NCBI
|
4
|
Tutar L, Özgür A and Tutar Y: Involvement
of miRNAs and pseudogenes in cancer. Methods Mol Biol. 1699:45–66.
2018. View Article : Google Scholar : PubMed/NCBI
|
5
|
Gabra MM and Salmena L: MicroRNAs and
acute myeloid leukemia chemoresistance: A mechanistic overview.
Front Oncol. 7:2552017. View Article : Google Scholar : PubMed/NCBI
|
6
|
Cheng L, Zhan B, Luo P and Wang B:
miRNA375 regulates the cell survival and apoptosis of human
nonsmall cell carcinoma by targeting HER2. Mol Med Rep.
15:1387–1392. 2017. View Article : Google Scholar : PubMed/NCBI
|
7
|
Poltronieri P: Editorial: Overview on
microRNAs in cancer development and virus infection. Microrna.
5:80–82. 2016. View Article : Google Scholar : PubMed/NCBI
|
8
|
Tutar L, Tutar E and Tutar Y: MicroRNAs
and cancer; an overview. Curr Pharm Biotechnol. 15:430–437. 2014.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Wang Y, Qiu C, Lu N, Liu Z, Jin C, Sun C,
Bu H, Yu H, Dongol S and Kong B: FOXD1 is targeted by miR-30a-5p
and miR-200a-5p and suppresses the proliferation of human ovarian
carcinoma cells by promoting p21 expression in a p53-independent
manner. Int J Oncol. 52:2130–2142. 2018.PubMed/NCBI
|
10
|
Ye YY, Mei JW, Xiang SS, Li HF, Ma Q, Song
XL, Wang Z, Zhang YC, Liu YC, Jin YP, et al: MicroRNA-30a-5p
inhibits gallbladder cancer cell proliferation, migration and
metastasis by targeting E2F7. Cell Death Dis. 9:4102018. View Article : Google Scholar : PubMed/NCBI
|
11
|
Guan Y, Rao Z and Chen C: miR-30a
suppresses lung cancer progression by targeting SIRT1. Oncotarget.
9:4924–4934. 2018. View Article : Google Scholar : PubMed/NCBI
|
12
|
Zhang C, Ma X, Du J, Yao Z, Shi T, Ai Q,
Chen X, Zhang Z, Zhang X and Yao X: MicroRNA-30a as a prognostic
factor in urothelial carcinoma of bladder inhibits cellular
malignancy by antagonising Notch1. BJU Int. 118:578–589. 2016.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Zhang S, Liu Q, Zhang Q and Liu L:
MicroRNA-30a-5p suppresses proliferation, invasion and tumor growth
of hepatocellular cancer cells via targeting FOXA1. Oncol Lett.
14:5018–5026. 2017. View Article : Google Scholar : PubMed/NCBI
|
14
|
Chen P, Liu H, Hou A, Sun X, Li B, Niu J
and Hu L: Prognostic significance of zinc finger E-box-binding
homeobox family in glioblastoma. Med Sci Monit. 24:1145–1151. 2018.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Verschueren K, Remacle JE, Collart C,
Kraft H, Baker BS, Tylzanowski P, Nelles L, Wuytens G, Su MT,
Bodmer R, et al: SIP1, a novel zinc finger/homeodomain repressor,
interacts with Smad proteins and binds to 5′-CACCT sequences in
candidate target genes. J Biol Chem. 274:20489–20498. 1999.
View Article : Google Scholar : PubMed/NCBI
|
16
|
He L, Yu K, Lu F, Wang J, Wu LN, Zhao C,
Li Q, Zhou X, Liu H, Mu D, et al: Transcriptional regulator ZEB2 is
essential for bergmann glia development. J Neurosci. 38:1575–1587.
2018. View Article : Google Scholar : PubMed/NCBI
|
17
|
Kan Q, Su Y and Yang H: MicroRNA-335 is
downregulated in papillary thyroid cancer and suppresses cancer
cell growth, migration and invasion by directly targeting ZEB2.
Oncol Lett. 14:7622–7628. 2017.PubMed/NCBI
|
18
|
Ko D and Kim S: Cooperation between ZEB2
and Sp1 promotes cancer cell survival and angiogenesis during
metastasis through induction of survivin and VEGF. Oncotarget.
9:726–742. 2017.PubMed/NCBI
|
19
|
Zhou X, Men X, Zhao R, Han J, Fan Z, Wang
Y, Lv Y, Zuo J, Zhao L, Sang M, et al: miR-200c inhibits
TGF-β-induced-EMT to restore trastuzumab sensitivity by targeting
ZEB1 and ZEB2 in gastric cancer. Cancer Gene Ther. 25:68–76. 2018.
View Article : Google Scholar : PubMed/NCBI
|
20
|
Liu P, Feng Y, Dong D, Liu X, Chen Y, Wang
Y and Zhou Y: Enhanced renoprotective effect of IGF-1 modifed human
umbilical cord-derived mesenchymal stem cells on gentamicin-induced
acute kidney injury. Sci Rep. 6:202872016. View Article : Google Scholar : PubMed/NCBI
|
21
|
Liu P, Cai J, Dong D, Chen Y, Liu X, Wang
Y and Zhou Y: Effects of SOX2 on proliferation, migration and
adhesion of human dental pulp stem cells. PLoS One.
10:e01413462015. View Article : Google Scholar : PubMed/NCBI
|
22
|
Liu P, Chen S, Li X, Qin L, Huang K, Wang
L, Huang W, Li S, Jia B, Zhong M, et al: Low immunogenicity of
neural progenitor cells differentiated from induced pluripotent
stem cells derived from less immunogenic somatic cells. PLoS One.
8:e696172013. View Article : Google Scholar : PubMed/NCBI
|
23
|
Tao S, Liu P, Luo G, Rojo de la Vega M,
Chen H, Wu T, Tillotson J, Chapman E and Zhang DD: p97 negatively
regulates NRF2 by extracting ubiquitylated NRF2 from the KEAP1-CUL3
E3 complex. Mol Cell Biol. 37:e00660–16. 2017. View Article : Google Scholar : PubMed/NCBI
|
24
|
Liu P, Feng Y, Dong C, Yang D, Li B, Chen
X, Zhang Z, Wang Y, Zhou Y and Zhao L: Administration of BMSCs with
muscone in rats with gentamicin-induced AKI improves their
therapeutic efficacy. PLoS One. 9:e971232014. View Article : Google Scholar : PubMed/NCBI
|
25
|
Huang K, Liu P, Li X, Chen S, Wang L, Qin
L, Su Z, Huang W, Liu J, Jia B, et al: Neural progenitor cells from
human induced pluripotent stem cells generated less autogenous
immune response. Sci China Life Sci. 57:162–170. 2014. View Article : Google Scholar : PubMed/NCBI
|
26
|
Yao Q, Pei Y, Zhang X and Xie B:
microRNA-96 acts as a tumor suppressor gene in human osteosarcoma
via target regulation of EZRIN. Life Sci. 203:1–11. 2018.
View Article : Google Scholar : PubMed/NCBI
|
27
|
Liu Y, Wu T, Song J, Chen X, Zhang Y and
Wan Y: A mutant screening method by critical annealing
temperature-PCR for site-directed mutagenesis. BMC Biotechnol.
13:212013. View Article : Google Scholar : PubMed/NCBI
|
28
|
Liu P, Zhang Y, Chen S, Cai J and Pei D:
Application of iPS cells in dental bioengineering and beyond. Stem
Cell Rev. 10:663–670. 2014. View Article : Google Scholar : PubMed/NCBI
|
29
|
Zhao L, Feng Y, Chen X, Yuan J, Liu X,
Chen Y, Zhao Y, Liu P and Li Y: Effects of IGF-1 on neural
differentiation of human umbilical cord derived mesenchymal stem
cells. Life Sci. 151:93–101. 2016. View Article : Google Scholar : PubMed/NCBI
|
30
|
Li Y, Zhang J, Liu Y, Zhang B, Zhong F,
Wang S and Fang Z: MiR-30a-5p confers cisplatin resistance by
regulating IGF1R expression in melanoma cells. BMC Cancer.
18:4042018. View Article : Google Scholar : PubMed/NCBI
|
31
|
Chen Z, Zhang J, Zhang Z, Feng Z, Wei J,
Lu J, Fang Y, Liang Y, Cen J, Pan Y, et al: The putative tumor
suppressor microRNA-30a-5p modulates clear cell renal cell
carcinoma aggressiveness through repression of ZEB2. Cell Death
Dis. 8:e28592017. View Article : Google Scholar : PubMed/NCBI
|
32
|
di Gennaro A, Damiano V, Brisotto G,
Armellin M, Perin T, Zucchetto A, Guardascione M, Spaink HP,
Doglioni C, Snaar-Jagalska BE, et al: A p53/miR-30a/ZEB2 axis
controls triple negative breast cancer aggressiveness. Cell Death
Differ. 25:2165–2180. 2018. View Article : Google Scholar : PubMed/NCBI
|
33
|
Wang HY, Li YY, Fu S, Wang XP, Huang MY,
Zhang X, Shao Q, Deng L, Zeng MS, Zeng YX and Shao JY: MicroRNA-30a
promotes invasiveness and metastasis in vitro and in vivo through
epithelial-mesenchymal transition and results in poor survival of
nasopharyngeal carcinoma patients. Exp Biol Med (Maywood).
239:891–898. 2014. View Article : Google Scholar : PubMed/NCBI
|
34
|
Lü L, Liu T, Gao J, Zeng H, Chen J, Gu X
and Mei Z: Aberrant methylation of microRNA-193b in human Barrett's
esophagus and esophageal adenocarcinoma. Mol Med Rep. 14:283–288.
2016. View Article : Google Scholar : PubMed/NCBI
|
35
|
Chen LL, Zhang ZJ, Yi ZB and Li JJ:
MicroRNA-211-5p suppresses tumour cell proliferation, invasion,
migration and metastasis in triple-negative breast cancer by
directly targeting SETBP1. Br J Cancer. 117:78–88. 2017. View Article : Google Scholar : PubMed/NCBI
|